Message Font: Serif | Sans-Serif
No. of Recommendations: 0
I have been following APPI, which merged into ABBI from its former holding company. It is now in a much better position to dramatically grow. It has several new FDA drug approvals, lots of cash, and its falgship drug, Abrzatane (sp?) continues to be confirmed a powerful cancer tumor fight agent. This is actualy a new nano tech delivery system, and should be the basis for use with other drugs. The only down side (and maybe this is not a negative at all) is that most of the stock is owned by one person, and the stock float is relatiavely small. I am not an analyst, and would appreciate any input any of you might have. On the surface, this looks like a probably multi bagger, but would appreciate other opinions. Incidentally, since the technology behind Abraxane is basically a new delivery system for old drugs, the FDA approval process is relatively fast.
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.